Morgan Stanley’s ArriVent BioPharma AVBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.21M | Sell |
101,354
-20,584
| -17% | -$448K | ﹤0.01% | 4637 |
|
|
2025
Q1 | $2.25M | Sell |
121,938
-26,646
| -18% | -$493K | ﹤0.01% | 4524 |
|
|
2024
Q4 | $3.96M | Sell |
148,584
-19,150
| -11% | -$510K | ﹤0.01% | 4190 |
|
|
2024
Q3 | $3.94M | Buy |
167,734
+126,350
| +305% | +$2.97M | ﹤0.01% | 4143 |
|
|
2024
Q2 | $768K | Buy |
41,384
+20,243
| +96% | +$376K | ﹤0.01% | 5111 |
|
|
2024
Q1 | $378K | Buy |
+21,141
| New | +$378K | ﹤0.01% | 5434 |
|